Trexquant Investment LP Protara Therapeutics, Inc. Transaction History

Trexquant Investment LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.8 - $5.33 $45,676 - $86,948	-16,313 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.19 - $6.9 $4,852 - $7,990	1,158 Added 7.64%	16,313 $83,000
Q4 2021 Feb 14, 2022	BUY	$6.15 - $7.76 $16,611 - $20,959	2,701 Added 21.69%	15,155 $102,000
Q3 2021 Nov 12, 2021	BUY	$6.38 - $9.3 $79,456 - $115,822	12,454 New	12,454 $86,000

10.7M

1.8K

Ticker TARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,267,400
Market Cap $26.9M
Description
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.